Rosyrah Kit
Product Images NDC 70700-312

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rosyrah (NDC 70700-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinyl Estradiol Structural Formula (Ethinyl Estradiol Structure)

Chemical structure of ethinyl estradiol, including its molecular formula C20H24O2 and molecular weight (MW) 296.4, displayed as a skeletal diagram with labeled functional groups.*

FDA Label Image

Figure 1: Likelihood Of Developing A Vte (Figure 1)

A horizontal bar chart titled 'Likelihood of Developing a VTE' comparing the number of women with a blood clot per 10,000 woman years among non-pregnant non-COC users, COC users, pregnant women, and postpartum women (12 weeks only). The chart shows increasing risk across these groups with ranges indicated for each category.*

FDA Label Image

Figure 2: Percent Of Women Taking Levonorgestrel And Ethinyl Estradiol Tablets And Ethinyl Estradiol Tablets Who Reported Unscheduled Bleeding And/or Spotting (Figure 2)

A bar chart showing the percentage of bleeding and/or spotting and bleeding alone across four menstrual cycles (Cycle 1 to Cycle 4) for different day ranges during the cycles. Each cycle displays two bars for bleeding and spotting combined and bleeding alone, with corresponding percentages and sample sizes noted below each cycle.*

FDA Label Image

Figure 3: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Figure 3)

A forest plot chart comparing effect estimates of 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never-Use' from multiple cohort studies, showing odds ratios, relative risks, and hazard ratios with confidence intervals plotted along an effect estimate axis ranging from -1.50 to 2.00. The chart includes studies from 2002 to 2017 related to combined oral contraceptive (COC) use.*

FDA Label Image

Levonorgestrel Structural Formula (Levonorgestrel Structure)

Chemical structure diagram of levonorgestrel, showing its molecular formula (C21H28O2) and molecular weight (312.4). The diagram depicts the steroid backbone and functional groups typical of levonorgestrel.*

FDA Label Image

Blister Card (Image 03)

Rosyrah oral contraceptive kit with 28 tablets organized in a 4-week calendar format. The label shows days of the week from Sunday to Saturday in rows labeled Week 1 through Week 4. It lists the active ingredients as levonorgestrel and ethinyl estradiol tablets in various dosages: 0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg, and 0.01 mg. The kit is from Xiromed, LLC with NDC 70700-312.*

FDA Label Image

Blister Card (Image 04)

Rosyrah oral contraceptive kit label showing a segmented 28-tablet layout for weeks 5 to 8 with days of the week labeled Sunday through Saturday. The label lists active ingredients levonorgestrel and ethinyl estradiol with multiple dosage strengths. The labeler is Xiromed, LLC, and the NDC is 70700-312.*

FDA Label Image

Blister Card (Image 05)

Rosyrah kit label showing a 35-tablet calendar layout for weekly oral administration from Sunday to Saturday over five weeks. The label lists the active ingredients as levonorgestrel and ethinyl estradiol tablets in various strengths (0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg, and 0.01 mg). The label includes the NDC 70700-312-87 and the manufacturer Xiromed, LLC.*

FDA Label Image

Carton (Image 06)

The image shows the carton packaging label for Rosyrah, a kit containing levonorgestrel and ethinyl estradiol tablets. The label highlights multiple dosages: 0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg, and 0.01 mg. It states the kit includes one pouch with an extended-cycle blister pack of 91 tablets. The labeler is Xiromed, LLC, and the product is Rx only.*

FDA Label Image

Pregnancy Chart (Pregnancy Chart)

An illustration diagram showing a vertical scale of pregnancy frequency, ranging from fewer pregnancies at the top to more pregnancies at the bottom. It categorizes birth control methods into five groups according to pregnancy rates per 100 women per year, from fewer than 1 pregnancy with methods like implants and sterilization, to 85 or more pregnancies with no birth control.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.